Upload
jade-stone
View
215
Download
1
Tags:
Embed Size (px)
Citation preview
Development of Rapid Through-put Nanotoxin Bioassays
Perry KanuryCassandra Viéville ~ Dr. Stacey Harper
CBEE/EMT
Background:
• Nanomaterials are widely used in both industrial and consumer applications
• Currently thousands of distinct compounds in use, with more introduced every dayo Found in every day products such as deodorant, sunscreen,
Teflon, pesticides, etc.
• Little or no knowledge of the true environmental or molecular impacts of these materialso Distinct lack of methods or protocols for toxicity testing
What are nanomaterials?
Materials with at least one dimension between1 and 100 nanometers
o Planar: Single dimension in ‘nano’ scale Example: Graphite sheet
o Tubular: Two dimensions in ‘nano’ scale Example: Bucky Tube
o Globular: Three dimensions in ‘nano’ scale Example: Bucky Ball
o Subcategory of nanomaterials
Formerly known as 'Ultra Fine Particles' At least two dimensions between 1 and 100 nanometers in diameter, implying either tubular or globular shapes Can take forms such as 'Nanoclusters', 'Nanocrystals', or 'Nanopowders' depending on agglomeration behavior
Wide range of applications including biomedical, optical and electronic fields
For reference: A typical nanoparticle has an effective diameter of approximately 1/800th that of a human hair.
What are nanoparticles?
Often exhibit unique structure-property characteristics as a result of volume to surface area ratio and surface structure
What does this mean to us?
Wide range of possible effects to both human and ecological systems
Examples:
Introduction of antimicrobial agents such as Aluminum Zirconium Tetrachlorohydrex (active ingredient in deodorant) into a town’s microbe-based water treatment system and subsequent watershed
Potential endocrine disruption (among additional myriad of effects) upon chronic exposure to Titanium Dioxide (active ingredient in many sunscreens) near lymph nodes, etc.
o Possible disruption of ‘Lock and Key’ hormone identification mechanisms within the Endocrine system.
Need:
• Rapid testing strategies are necessary to identify specific nanomaterials that result in toxicity in order to mitigate risks from exposure and define structure-property relationships that can be used to predict nanomaterial fate and hazard in lieu of empirical data.
Hypothesis:
An aquatic ecosystem can be modeled in the form of a ‘nanocosm’ ~ an extremely small tritrophic ecosystem (250 uL).
Prediction:
This ecosystem can be effectively used for the purpose of assessing the toxicity of nanoparticles in aquatic environments, as well as modeling the impacts of these nanoparticles on said ecosystems.
Another way of looking at it:
‘Nano’ Algae Ciliate Bacteria
Varying nanoparticle exposures
(All 3 organisms)
o Tri-trophic aquatic ecosystem based upon our local temperate region Photo-synthesizer (primary producer):
Chlamydomonas reinhardtii (green algae) Predator (primary consumer): Tetrahymena
thermophilia (ciliate) Decomposer (detritovore): E.coli (bacteria)
o Suspended in a defined microbial mediao Upon exposure by nanotoxins, can monitor
population dynamics and predator/prey interactions to understand effects. Varying nanoparticle exposures
The makeup and utilization of a Nanocosm:
‘Nano’ Algae Ciliate Bacteria(All 3 organisms)
Typical Plate Layout
0.01 ppm
0.05 ppm
0.1 ppm
0.5 ppm
1 ppm
5 ppm
10 ppm
50 ppm
Nano Bacteria Algae Ciliate
Three replicates of each treatment for each organism
Exposure Concentration
How we observe these interactions:
Flow Cytometer
Cell Concentration (cells/uL) of each organism are obtained and analyzed based upon effective size and fluorescence.
Quantifies and categorizes cells via light diffraction and fluorescence.
‘Nano’ Algae Ciliate Bacteria(All 3 organisms)
Varying nanoparticle exposures
Treatment is observed relative to negative control within the same timepoint (((treatment-control)/control)*100)
How we observe these interactions:
Concentration Response
Future Work:
• Investigation of more ideal organisms than Tetrahymena thermophilia in order to streamline data collection utilizing existing equipment
• Investigation of additional endpoints beyond mortality• Investigation of possible mechanisms of toxicity• Establishment of a database of the effects of various
nanotoxin exposures.